Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases

CE Raptis; C Polysopoulos; CT Berger; A Ciurea; DO Andrey; T Maletic; M Riek; A Scherer; von Loga; J Safford; K Lauper; B Moeller; N Vuilleumier; A Finckh; A Rubbert-Roth

doi:10.57187/smw.2023.40135

Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases

CE Raptis, C Polysopoulos, CT Berger, A Ciurea, DO Andrey, T Maletic, M Riek, A Scherer, von Loga, J Safford, K Lauper, B Moeller, N Vuilleumier, A Finckh, A Rubbert-Roth

Division of Musculoskeletal & Dermatological Sciences

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	11S
Number of pages	1
Journal	Swiss Medical Weekly
Volume	153
Issue number	8 S271
DOIs	https://doi.org/10.57187/smw.2023.40135
Publication status	Published - 28 Aug 2023
Event	Annual meeting of the Swiss Society of Rheumatology 2023 - Interlaken, Switzerland Duration: 31 Aug 2023 → 1 Sept 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.57187/smw.2023.40135Licence: CC BY

Cite this

Raptis, CE., Polysopoulos, C., Berger, CT., Ciurea, A., Andrey, DO., Maletic, T., Riek, M., Scherer, A., Loga, V., Safford, J., Lauper, K., Moeller, B., Vuilleumier, N., Finckh, A., & Rubbert-Roth, A. (2023). Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases. Swiss Medical Weekly, 153(8 S271), 11S. https://doi.org/10.57187/smw.2023.40135

@article{a726df3d8609471e944442b92745ab50,

title = "Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases",

author = "CE Raptis and C Polysopoulos and CT Berger and A Ciurea and DO Andrey and T Maletic and M Riek and A Scherer and von Loga and J Safford and K Lauper and B Moeller and N Vuilleumier and A Finckh and A Rubbert-Roth",

year = "2023",

month = aug,

day = "28",

doi = "10.57187/smw.2023.40135",

language = "English",

volume = "153",

pages = "11S",

journal = "Swiss Medical Weekly",

issn = "1424-7860",

publisher = "EMH Swiss Medical Publishers Ltd",

number = "8 S271",

note = "Annual meeting of the Swiss Society of Rheumatology 2023 ; Conference date: 31-08-2023 Through 01-09-2023",

}

Raptis, CE, Polysopoulos, C, Berger, CT, Ciurea, A, Andrey, DO, Maletic, T, Riek, M, Scherer, A, Loga, V, Safford, J, Lauper, K, Moeller, B, Vuilleumier, N, Finckh, A & Rubbert-Roth, A 2023, 'Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases', Swiss Medical Weekly, vol. 153, no. 8 S271, pp. 11S. https://doi.org/10.57187/smw.2023.40135

TY - JOUR

T1 - Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases

AU - Raptis, CE

AU - Polysopoulos, C

AU - Berger, CT

AU - Ciurea, A

AU - Andrey, DO

AU - Maletic, T

AU - Riek, M

AU - Scherer, A

AU - Loga, von

AU - Safford, J

AU - Lauper, K

AU - Moeller, B

AU - Vuilleumier, N

AU - Finckh, A

AU - Rubbert-Roth, A

PY - 2023/8/28

Y1 - 2023/8/28

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001059245500014&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.57187/smw.2023.40135

DO - 10.57187/smw.2023.40135

M3 - Meeting Abstract

SN - 1424-7860

VL - 153

SP - 11S

JO - Swiss Medical Weekly

JF - Swiss Medical Weekly

IS - 8 S271

T2 - Annual meeting of the Swiss Society of Rheumatology 2023

Y2 - 31 August 2023 through 1 September 2023

ER -

Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases

UN SDGs

Access to Document

Other files and links

Cite this